B.M.P. PHARMA TRAD (BMP.SG) (BMP) — Strategic Asset Allocation Index
B.M.P. PHARMA TRAD (BMP.SG) (BMP) has a Strategic Asset Allocation Index of 66.4% as of December 2016. Strategic assets (PP&E of €635.00 plus long-term investments of €3.41 Million) total €3.41 Million, measured against net assets of €5.14 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See B.M.P. PHARMA TRAD (BMP.SG) (BMP) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
B.M.P. PHARMA TRAD (BMP.SG) Strategic Asset Allocation Index (2013–2016)
This chart shows how B.M.P. PHARMA TRAD (BMP.SG)'s Strategic Asset Allocation Index has evolved across 4 annual periods from 2013 to 2016. As of December 2016, the index stands at 66.4%, representing strategic assets of €3.41 Million against net assets of €5.14 Million EUR. For live market cap and overall valuation, see B.M.P. PHARMA TRAD (BMP.SG) (BMP) total market value.
Annual Strategic Asset Allocation Index for B.M.P. PHARMA TRAD (BMP.SG) (2013–2016)
The table below presents the year-by-year Strategic Asset Allocation Index for B.M.P. PHARMA TRAD (BMP.SG) from 2013 to 2016, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See B.M.P. PHARMA TRAD (BMP.SG) (BMP) shareholders funds for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2016 | 66.4% | €3.41 Million | €635.00 | €3.41 Million | €5.14 Million | ▲ +0.1 pp |
| 2015 | 66.3% | €3.41 Million | €- | €3.41 Million | €5.15 Million | ▼ -5.4 pp |
| 2014 | 71.7% | €3.41 Million | €- | €3.41 Million | €4.76 Million | ▼ -0.6 pp |
| 2013 | 72.3% | €3.41 Million | €- | €3.41 Million | €4.72 Million | — |